Lung stents are small, wire mesh tubes that are inserted into the airways of the lungs to help keep them open. They are used to treat conditions that narrow the airways such as lung cancer, chronic bronchitis and emphysema. Lung stents help improve breathing and lung functions by reducing obstruction in the airways. The demand for lung stents is increasing due to the rising prevalence of chronic obstructive pulmonary disease (COPD) and lung cancer worldwide. The development of novel stent designs that are less invasive and associated risks continue to drive the adoption of lung stents.

The Global Lung Stent Market is estimated to be valued at US$ 236.87 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024 To 2031.

Key Takeaways
Key players operating in the Global Lung Stent market are Boston Scientific, Cook Medical, Medtronic, Taewoong Medical, Hospitech, Bess, Endo-Flex, Efer Endoscopy, W. L. Gore & Associates, BD, Edwards Lifesciences, Healthy Medical Corporation, Pulmonx Corporation, Meril Life Sciences Pvt. Ltd and C. R. Bard Inc. The key players are focusing on developing innovative stent designs and delivery systems. For instance, Pulmonx Corporation offers Zephyr Endobronchial Valve, a minimally invasive treatment option for severe emphysema.

The rising prevalence of lung cancer and COPD presents significant growth opportunities for players in the Global Lung Stent Market Demand . Moreover, the increasing preference for minimally invasive procedures for lung treatment is encouraging technology advancements in stent designs. Manufacturers are investing in developing bioabsorbable stents and valves to reduce complications associated with permanent stents.

Recent advancements such as magnetically controlled stents and valved stents have enhanced delivery accuracy and improved lung functioning. Ongoing R&D to develop patient-specific 3D printed stents with advanced visualization also bodes well for the market.

Get more insights on - Global Lung Stent Market